Bringing you live news and features since 2006 

Cipher Surgical raises GBP250,000 in less than four weeks with VentureFounders


VentureFounders, the UK-based equity investment platform for sophisticated investors, has today announced that a GBP250,000 fundraise for

Cipher Surgical has completed a GBP250,000 fundraise in less than four weeks via VentureFounders, a UK-based equity investment platform for sophisticated investors.
Cipher’s OpClear device uses patented technology to make abdominal keyhole surgery quicker and safer for both surgeons and patients. The device directs a short controlled jet of carbon dioxide and saline across the laparoscope's lens to keep it clear of contaminants such as condensation or blood during a procedure, without having to repeatedly remove the scope from the patient.
Cipher Surgical has now raised in excess of its GBP1.65 million target in Enterprise Investment Scheme (EIS) eligible equity during 2015, at a pre-money valuation of GBP7 million. The campaign started overfunding 25 days after launching on VentureFounders and the total is now over GBP1.75 million.
Commitments are still being taken from VentureFounders’ investors until the campaign closes, which is expected to be early December.
James Codling, Co-Founder & Managing Director of VentureFounders, says: “Cipher Surgical is an ambitious company at an important point in its expansion plans. The company clearly resonates with investors, with the company now taking an overfund on the total raise to date. We expected this campaign to gain great traction having been particularly impressed by the company’s experienced management team, which has a strong track record in all aspects of medical device development. It’s also great to see state of the art technology offering a real solution to a problem faced by many surgeons.”
Andrew Newell, CEO of Cipher Surgical, adds: “We are delighted by the traction we have received from our fundraise on VentureFounders. We have previously seen the benefits of successful fundraising, and the money raised through this round will support the completion and launch of OpClear in Europe and also the FDA submission for US market entry. We are also planning a larger raise in 2016 to support the US rollout of OpClear.”

Latest News

Morningstar has published a review of the European ETF market for the first quarter 2024, which finds that it gathered..
ETF data consultant ETFGI reports that assets invested in the global ETF industry reached a new record of USD12.71 trillion..
Calastone has published an ETF white paper which examines several of the processes that take place across the lifecycle of..
Adapting product lines to fit into changing methodologies and meet shifting demand is essential to remaining relevant in the industry..

Related Articles

US ETF issuers of active ETFs are facing an increase in fees from the big custodian firms, such as Charles...
Taylor Krystkowiak, Themes ETFs
Themes ETFs opened its doors in December 2023, with an introductory suite of 11 ETFs – seven thematic and four...
Konrad Sippel, Solactive
At the end of March, financial index specialist, Solactive, published its 2024 annual report on future trends.  ...
Lorraine Sereyjol-Garros, BNP Paribas
Following changes to the French Monetary and Financial Code and of the French market authority AMF’s General Regulation, it is...
Subscribe to the ETF Express newsletter

Subscribe for access to our weekly newsletter, newsletter archive, updates on the site and exclusive email content.

Marketing by